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Abstract
Tumor cells are stressed by unfavorable environmental conditions like hypoxia or starvation. Driven by the resulting cellular
stress tumor cells undergo epithelial-mesenchymal transition. Additionally, cellular stress is accompanied by endoplasmic
reticulum-stress which induces an unfolded protein response. It is unknown if epithelial-mesenchymal transition and
endoplasmic reticulum-stress are occurring as independent parallel events or if an interrelationship exists between both of
them. Here, we show that in colorectal cancer cells endoplasmic reticulum-stress depends on the induction of ZEB-1, which
is a main factor of epithelial-mesenchymal transition. In the absence of ZEB-1 colorectal cancer cells cannot mount
endoplasmic reticulum-stress as a reaction on cellular stress situations like hypoxia or starvation. Thus, our data suggest that
there is a hierarchy in the development of cellular stress which starts with the presence of environmental stress that induces
epithelial-mesenchymal transition which allows finally endoplasmic reticulum-stress. This finding highlights the central role
of epithelial-mesenchymal transition during the process of tumorigenesis as epithelial-mesenchymal transition is also
associated with chemoresistance and cancer stemness. Consequently, endoplasmic reticulum-stress might be a well suited
target for chemotherapy of colorectal cancers.
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Introduction
Colorectal carcinoma (CRC) belongs to the most prevalent
cancer types in the Western world. Many CRCs are characterized
by infiltrative growth which is associated with epithelial-mesen-
chymal transition (EMT). EMT is frequently seen at the invasive
front of CRCs and is accompanied by an increased expression of
mesenchymal marker genes like vimentin [1,2]. Prerequisites for
EMT are changes in the epithelial phenotype of tumor cells, like
loss of epithelial polarity and the zonula adhaerentes as well as a
gain of mobility [1,2]. Loss of zonula adhaerentes is mediated by
downregulation of E-cadherin, a cell adhesion molecule localized
at the cell membrane of epithelial cells. Transcription of E-
cadherin during EMT is regulated by different transcriptional
repressors like zinc finger E-box binding protein (ZEB1), which
represents the most important factor for EMT induction in CRCs
[3–5]. ZEB1 was found immunhistochemically at the front of
invasion in colorectal carcinomas but not in central tumor areas
supporting the importance of ZEB1 for EMT [6].
In the zonula adhaerentes E-cadherin is linked to b-catenin
which is also a component of the canonical Wnt signaling pathway
that is frequently deregulated in CRCs [7]. Loss of E-cadherin
causes the release of b-catenin from the zonula adhaerentes. As a
consequence b-catenin might enter the nucleus where it associates
with members of the T-cell factor (TCF)/lymphocyte enhancing
factor-1 (LEF1) family. Such dimers are the central element of a
multiprotein complex that promotes transcription of b-catenin
target genes which mediate migration, invasion, EMT and other
hallmarks of cancer [7,8].
Due to their high proliferation and metabolism on the one hand
and poor vascularisation of tumors on the other hand, tumor cells
suffer from pathophysiological environmental conditions like
glucose starvation, hypoxia, acidosis, low pH value and others.
In particular hypoxia is an important driver of tumorigenesis. It is
mainly regulated by the transcriptional activator hypoxia-induc-
ible factor-1 (HIF1), a heterodimer composed of the subunits
HIF1a and HIF1b. During hypoxia HIF1a degradation is blocked
and HIF1a accumulates subsequently also in the nucleus. Here,
HIF1a dimerizes with HIF1b and the resulting HIF1 complex
binds to specific hypoxia responsive elements in the promoter/
enhancer region of its target genes, thereby activating the
angiogenic switch. This leads to reperfusion and thus to an
increase in oxygen availability and thus a release of hypoxia [9,10].
Hypoxia also affects the function of the endoplasmic reticulum
(ER) causing an accumulation of unfolded, misfolded or aggre-
gated proteins within the ER lumen. This leads to an imbalance
between the cellular demand for ER-function and ER-capacity
resulting in ER-stress [11]. To reduce ER-stress and to ensure cell
survival, a highly conserved intracellular signalling cascade, the
PLOS ONE | www.plosone.org 1 January 2014 | Volume 9 | Issue 1 | e87386
unfolded protein response (UPR), is initiated. UPR is accompa-
nied by the activation of different ER-resident transmembrane
stress sensors, like the activating transcription factor-6 (ATF6)
[12]. In the absence of cellular stress the function of the stress
sensors is blocked by the molecular chaperone 78 kD glucose-
regulated protein (GRP78), which is located in the ER lumen and
the key protein initiating ER-stress response [12]. Under cellular
stress misfolded proteins accumulate and bind to GRP78 resulting
in the release and activation of the stress sensors [12,13]. When
GRP78 dissociates from ATF6 it translocates into the Golgi
complex, where it is cleaved into a transcriptionally active 50 kD
fragment that subsequently enters the nucleus. Here, it binds to
ER-stress response elements of several genes like GRP78 and
activate their expression. Thus, both enhanced GRP78 amounts
and the presence of the 50 kD ATF6 cleavage product are
indicators of an ER-stress response [14].
It is noteworthy that EMT and hypoxia have several
characteristics in common, like induction of invasiveness, expres-
sion of mesenchymal marker genes as vimentin [1,2] as well as the
loss of E-cadherin [1,2,15,16]. Interestingly, at the invasive front of
CRCs, tumor cells displaying EMT [1,2] are characterized by
nuclear b-catenin as well as nuclear HIF1a [2,17]. Thus, ER-stress
on the one hand, and EMT on the other hand occur in parallel in
tumor cells. It is currently unknown if there is an interrelation
between EMT and ER-stress which might connect the two main
drivers of colorectal carcinogenesis namely Wnt/b-catenin signal-
ling and hypoxia. Here, we show that EMT induces an ER-stress
response which assists in and raises tumor cell survival.
Materials and Methods
According to the guidelines of our University, immunohisto-
chemical staining of archived tissue samples may be performed
provided that anonymity is granted. Therefore, approval of this
study was waived by the ethical committee of the University of
Munich.
Cell Culture
The human cultured CRC cell lines SW480 and HCT116
(American Type Culture Collection, Manasas, VA, USA) are both
characterized by aberrantly activated Wnt/b-catenin signaling
[18]. The SW480 derivatives SW480-shZEB1 (with stable short
hairpin RNA (shRNA)-mediated knockdown of ZEB1, further
designated as SW480-shZEB1) and SW480-shGFP (stably express
ZEB1 and shGFP (green fluorescent protein (GFP), further
designated as SW480-controls) were used kindly provided by Prof.
Th. Brabletz, Freiburg, Germany [3]. All cell lines were cultured
in Dulbecco’s modified essential medium (DMEM)/Ham’s F12
(1:1) medium with stable L-glutamine (365.3 mg/l; Biochrom,
Berlin, Germany) and 10% (v/v) fetal bovine serum (FBS) at 37uC
in a humified 5% CO2 atmosphere. The identity of all cell lines
was authenticated at the DSMZ (Deutsche Sammlung für
Mikroorganismen und Zellkulturen GmbH, Braunschweig, Ger-
many) in September, 2011 and then rechecked semiannually in the
laboratory using the same marker set as DSMZ.
EMT induction
Two methods were used for the induction of EMT. 1. growth
density [19]. Therefore, for each experiment tumor cells were
seeded at high density (,76104/cm2) on a petri dish (10 cm
diameter) and harvested after 72–96 h at confluence, when they
displayed an epithelial phenotype [19]. Additionally cells were
seeded at low density (,76103/cm2) on three petri dishes (10 cm
diameter) and harvested after 48–52 h when they exhibited a
mesenchymal phenotype. Four experiments were conducted per
cell line each consisting of one low density and two confluent
growing samples. 2. serum starvation [20]. Therefore, tumor cells
were seeded on petri dishes (3 cm diameter) and grown to
confluence in normal culture medium. Then cells were either
grown for additional 12 h in normal medium, or serum starved for
6 h in serum-free medium which was replaced by FBS containing
medium. Cells were harvested after 6 h. Serum starvation
experiments were conducted three times.
Induction of hypoxia and reoxygenation
For the induction of hypoxia confluent growing SW480 and
HCT116 cells seeded on petri dishes (3 cm diameter) were treated
with 100 mM of cobalt chloride (CoCl2) (Sigma-Aldrich, Tauf-
kirchen, Germany), in serum free medium for 1–9 h [21]. For
reoxygenation confluent growing SW480-shZEB1 cells and
SW480-controls seeded on petri dishes (3 cm diameter) were
treated with 100 mM CoCl2 in serum free medium for 6 h. After
washing cells were incubated in normal medium without CoCl2
and harvested after 0.5 h, 1.0 h and from then on in 3.0 h
intervals up to 24 h. Both experiments were done three times.
Preparation of protein samples
For the determination of EMT-associated proteins by two-
dimensional electrophoresis (2-DE) whole cellular proteins were
extracted from confluent and sparsely growing SW480 and
HCT116 cells [22]. Protein samples were mixed with urea (9M),
DTT (70 mM) (both BioRad, Munich, Germany) and Ampholytes
(2%, Servalytes pH 5–7, Serva, Heidelberg, Germany), cleared by
centrifugation (14,000 rpm/10 min/4uC) and frozen in liquid
nitrogen. For standard polyacrylamide gel electrophoresis (PAGE)
proteins were extracted with triple-detergent lysis buffer [23]
supplemented with a protease inhibitor cocktail [22], cleared by
centrifugation and finally frozen in liquid nitrogen.
Protein detection
Changes in EMT-associated protein composition were deter-
mined by comparative proteome analysis employing 2-DE and
matrix–assisted laser-desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF MS). Protein samples were separated
by high-resolution 2-DE using the Iso-Dalt-equipment (Hoefer
Scientific Instruments, Kehl, Germany). 75 mg (analytical scale) or
400 mg (preparative scale) proteins were separated in the first
dimension by isoelectric focusing [24]. Separation in the second
dimension was done using polyacrylamide gradient gels (10%–
16%) followed by silver- or Coomassie Brilliant Blue staining
(CBB; R250, Merck, Germany) [24]. 2-DE gels resulting from
either epithelially (confluent) or mesenchymally (sparsely) grown
SW480- or HCT116 cells respectively were compared per cell line
pair wise. Protein spots showing differences in intensities were
verified by cross comparison of all 2-DE gels within one series
[25]. Gel comparisons were done using the image analysis software
program TOPSPOT (http://www.mpiib-berlin.mpg.de/2D-
PAGE/). An entire 2-DE gel is shown in Figure S1A.
Protein identification
For protein identification spots of interest were excised from
CBB-stained gels and subjected to tryptic in-gel digestion. Peptide
masses were determined by the protein analysis unit at the Adolf-
Butenandt-Institute of the university of Munich using a MALDI-
TOF mass spectrometer (Voyager-DESTR, Applied Biosystems,
Darmstadt, Germany) and identified by peptide mass fingerprint-
ing (PMF) searching National Centre for Biotechnology Informa-
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tion and SwissProt databases using the MS-Fit (http://prospector.
ucsf.edu/) and PeptIdent software (http://au.expasy.org/tools/
peptident.html), respectively.
Sodium dodecyl-sulfate (SDS)-PAGE and immunostaining were
used for all subsequent studies [25]. Protein samples were enriched
with 2XSDS sample buffer (final concentration: 2% (w/v) SDS,
70 mM DTT, 10% (v/v) Glycerol), resolved using Mini Protean
IITM devices (BioRad) using 10% (w/v) polyacrylamide gels,
transferred onto hydrophobic polyvinylidene difluoride (PVDF)
membranes (pore diameter 0.2 mm, BioRad) under semi dry
conditions (1 h at 1 mA/cm2), blocked for 1 h in phosphate
buffered saline (PBS)/0.1% (v/v) Tween20, 5% (w/v) non-fat dry
milk powder (BioRad), incubated overnight (4uC) in the presence
of the first antibody and treated with the appropriate horseradisch
peroxidase (HRP)-conjugated secondary antibody. The signals
were routinely intensified employing enhanced chemolumines-
cence (ECL) or ECL-advanced detection kits (GE Healthcare,
Buckinghamshire, UK).
Statistical analysis
To evaluate significance of changes in protein amount Student’s
t-tests were applied, two sided p-values of p#0.05 were taken as
statistically significant. Cross-tabulations were calculated using
Chi-quadrat test. For statistical analyses SPSS version 15.0 (SPSS
Inc.) was used.
Antibodies used for Western blotting
The following antibodies were applied: anti-ATF6 (1:10,000;
clone 70B1413.1; Imgenex, Hamburg, Germany), anti-b-actin
(1:10,000; clone AC-15; Sigma-Aldrich), anti-GRP78/Bip
(1:10,000; clone Gl-19; Sigma-Aldrich), anti-HIF1a (1:500; clone
54; BD Transduction, Heidelberg, Germany), anti-vimentin
(1:4,000; clone H-84; Santa Cruz Biotechnology Inc., Heidelberg,
Germany) and anti-ZEB1 (1:500; HPA027524; Sigma-Life
Science). For the quantification of ZEB1 its full length 170 kD
form (arrow, Figure S1C) was taken (Swiss-Prot; Acc: P37275). For
SDS-PAGE 25 mg protein were applied usually. For the detection
of HIF1a, ZEB1 and ATF6 50 mg of protein were applied on gels.
Specificity of the antibodies was checked by immunoblotting
(Figure S1C).
Immunofluorescence (IF)
SW480 and HCT116 cells were seeded on 12 mm round
coverslides. After reaching appropriate densities, for EMT either
as confluent or sparsely growing [19], and as confluent growing
cultures for CoCl2 treatment (3 h, 100 mM CoCl2, serum free)
[21], cells were fixed in the presence of 2% (v/v) formaldehyde.
The following antibodies were employed: anti-b-catenin (1:150;
clone 14/Beta-Catenin, BD Biosciences, NJ, USA) and anti-E-
cadherin (1:100; clone EP6; Epitomics Burlingame, UK). Anti-
bodies were diluted in 0.1% (w/v) saponin, counterstained with
anti-Alexa-FluorH488 (Invitrogen, Karlsruhe, Germany) and
finally mounted in mounting medium containing DAPI (Vector
Vectrashield Laboratories, Dossenheim, Germany). Immunofluo-
rescence staining was detected by immunofluorescence-microsco-
py (Zeiss Axioscope 50, Zeiss Axiocam MRc).
Patient Material
Formalin-fixed paraffin-embedded (FFPE) tissue from 16 CRC
tumor cases was taken from the archives of the Department of
Pathology, Ludwig-Maximillians Universität, München. Our
study enrolled invasive colorectal adenocarcinomas pT2 and
pT3 where single cells with mesenchymal morphology and nuclear
b-catenin expression were found at the invasive front. The study
complied with the requirements of the Ethics Committee of the
Ludwig-Maximilian Universität of Munich.
Immunohistochemistry (IHC)
Tissue sections (4 mm) of FFPE of human CRCs were prepared.
For IHC the same antibodies as for Western blotting and IF were
applied except for anti-HIF1a (clone EP1215Y; Epitomics,
Burlingame, UK) which was used for IHC only. Endogenous
peroxidase of sections was inhibited by 7.5% H2O2 at room
temperature. Second antibody was used according to the ABC-Kit
instructions. Slices were counterstaining for 10 sec. in Hematox-
ylin (Gill’s Formula; Vector Laboratories), and coverslipped with
Kaiser’s glycerol gelatin (Merck) (Table S1).
Results
Induction of EMT in CRC cell lines by altering growth
density
First of all, we validated the experimental setup. For mimicking
EMT in vitro SW480 and HCT116 cells were grown under
different growth densities. The subcellular localization of b-catenin
was taken as an indicator for epithelial- or mesenchymal
organization using IF microscopy. Confluent growing tumor cells
displayed an epithelial morphology characterized by the mem-
branous localization of b-catenin (Figure 1A a, b). In contrast
sparsely growing cells acquired a mesenchymal phenotype
accompanied by a nuclear localization of b-catenin (Figure 1A c,
d). Thus, the chosen experimental system allowed the growth of
SW480 and HCT116 tumor cells resulting in an epithelial- or
mesenchymal differentiation.
Comparison of protein level in confluent and sparsely
grown tumor cells
To investigate the effect of EMT on the constitution of the
proteome, we compared 2-DE protein patterns of SW480 and
HCT116 cells. The identity of at least thirty protein spots which
showed a significant quantitative difference in intensity between
confluent and sparse growth was determined by PMF. The
significant increase in amount of the EMT indicator and
mesenchymal marker protein vimentin [1,2] in sparsely growing
cells confirmed, that the chosen conditions in this experimental
setting resulted in the differentiation between epithelial- and
mesenchymal growth of the tumor cells (SW480: 5.8–fold,
p = 0.0015, Figure 1B a, b, c; HCT116: 3.6-fold p = 0.01,
Figure 1B d, e, f). Seven proteins were attributed as members of
protein families of molecular chaperones. GRP78 attracted our
attention due to its high protein amount found in sparsely growing
cells, and its highly significant difference in the two growth
patterns (SW480: 3.3-fold, p = 0.0005, Figure 1B a, b, c; HCT116:
2-fold, p = 0.0005, Figure 1B d, e, f; single analyzed 2-DE areas
are shown in Figure S1B). As GRP78 is a well-known indicator of
an ER-stress response [11,13] its elevation indicated an intercon-
nection between EMT and ER-stress response. Our view was
supported by the finding of considerable amounts of the 50 kD-
fragment of the stress sensor ATF6 in protein extracts of sparsely
grown tumor cells (Figure S1D).
Hypoxia induces both EMT and ER-stress in CRC cell lines
To validate the interrelationship of EMT and ER-stress we used
the well-known stressor hypoxia. In lack of a hypoxic chamber we
applied CoCl2 to simulate a hypoxia-like state in our cellular
model [26,27]. Therefore, confluent growing SW480- and
EMT Induces ER-Stress Response
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HCT116 cells were exposed to CoCl2 for 1–9 h. Induction of a
hypoxia-like state was found already 3 h after addition of CoCl2
by the appearance of HIF1a (Figure S2B, C).
IF-microscopy approved that under these conditions tumor cells
displayed comparable molecular and morphological changes
typical for EMT. SW480 cells lost cellular contacts and b-catenin
and E-cadherin were dislocated from the membrane. b-catenin
was mainly found in the cell nucleus and E-cadherin in the
cytoplasm (Figure S2A a–f). HCT116 cells sustained cell contact,
but b-catenin was no longer persistently but punctually arranged
at cell margins. Moreover, the majority of b-catenin was now
found in the cells’ nuclei. E-cadherin was lost from the membrane
and found in the cytoplasm (Figure S2A g–m). Additionally
immunoblotting showed significant increased amounts of vimentin
(H (hypoxia) 1 h: 1.2-fold, p = 0.095; H 3 h: 1.3-fold, p = 0.0003;
H 6 h: 1.4-fold, p = 0.021; H 9 h: 1.3-fold, p = 0.0002 in SW480
cells and H 3 h: 1.22-fold, p = 0.116; H 6 h: 1.45-fold, p = 0.009 in
HCT116 cells).
GRP78 and the 50 kD-fragment of the stress sensor ATF6 were
also clearly elevated after 3 h in both cell lines using immuno-
blotting, thus indicating ER-stress (Figure S2B, C and D; GRP78:
H 1 h: 1.04-fold, p = 0.42-fold; H 3 h: 1.18-fold, p = 0.019; H 6 h:
1.25-fold, p = 0.015; H 9 h: 1.29-fold, p = 0.02 in SW480 cells and
H 3 h: 1.16-fold, p = 0.079; H 6 h: 1.3-fold, p = 0.004 in HCT116
cells).
Therefore the simulation of a hypoxia-like state applying CoCl2
caused both EMT and ER-stress in parallel.
EMT is a prerequisite for induction of an ER-stress
response in CRC cell lines
Next, we wanted to investigate if there is a causative relationship
between EMT and ER-stress response. Therefore we enrolled
SW480-shZEB1 cells, which are characterized by their inability to
undergo EMT [3]. Under conditions of sparse growth SW480-
shZEB1 cells displayed significant lower signs of EMT indicated
by vimentin but also less ER-stress indicated by GRP78 compared
to SW480-control cells (SW480-shZEB1: vimentin: 0.9-fold,
p.0.05; GRP78: 0.7-fold, p.0.05; SW480-control: vimen-
tin:1.4-fold, p = 0.048; GRP78: 1.6-fold, p = 0.004; Figure 2A).
Next, we employed serum starvation as a second way to induce
ER-stress [18]. Comparable results to conditions of sparse growth
were found. In SW480-shZEB1 cells vimentin and GRP78
elevation was significant lower than in SW480-control cells
(SW480-shZEB1: vimentin: 1.3-fold, p.0.05; GRP78: 1.02-fold,
p.0.05; SW480-control: vimentin: 1.9-fold, p = 0.049; GRP78:
1.9-fold, p = 0.04; Figure 2B).
In a third approach SW480-shZEB1 and – SW480-control cells
were grown to confluence and then incubated for 6 h in CoCl2
containing medium, as both EMT and ER-stress were pronounced
after this time (Figure S2A, B and D). In this setting the amount of
vimentin as well as GRP78 was not enhanced in SW480-shZEB-1
cells but considerably increased in SW480 controls similar to both
preceding experiments (SW480-shZEB1: vimentin: 1.2-fold,
p.0.05; GRP78: 0.8-fold, p.0.05; SW480-control: vimentin:
1.62-fold, p = 0.038; GRP78: 1.35-fold, p = 0.04; Figure 2C).
Taken together, EMT turned out to be a prerequisite for the
induction of an ER-stress response.
Figure 1. EMT is associated with an ER-stress response in CRC
cell lines. A. Confluent growing SW480 cells are characterized by an
epithelial growth pattern with membranous localization of b-catenin (a;
green fluorescence). Sparsely growing cells, mimicking EMT display a
mesenchymal growth pattern with cytoplasmic/nuclear localization of
b-catenin (c; green fluorescence). Nuclei were counterstained by DAPI
staining (b, d; blue fluorescence). (Magnification 6306). B. Quantitative
changes in protein amount of the EMT-associated proteins vimentin
(Vim) (located in 2-DE gels at 55.0 kD/pI 5.1) (arrows) and GRP78
(76.0 kD/pI 5.0) are presented in selected 2-DE areas: a. confluent
SW480 cells; b. sparsely growing SW480 cells; c. quantification of the
amount (n-fold) of vimentin (Vim) and GRP78 in confluent and sparsely
growing SW480 cells d. confluent HCT116 cells; e. sparsely growing
HCT116 cells. f. quantification of the amount (n-fold) of vimentin (Vim)
and GRP78 in confluent and sparsely growing HCT116 cells. Data shown
is the mean 6 standard deviation (SD) from four independent
experiments; * : p#0.05.
doi:10.1371/journal.pone.0087386.g001
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Coupling of EMT and ER-stress response as well as
hypoxia are also found in human CRCs
We wanted to validate if our findings were also found in human
CRCs. Therefore serial sections of 16 CRCs with an elaborated
invasion front containing mesenchymally differentiated cells were
stained immunohistochemically with b-catenin, GRP78 and
HIF1a. In central areas of tumors, where tumor cells displayed
an epithelial phenotype, b-catenin was found mainly associated
with the membrane (16/16 cases, 100%), while weak or absent
staining was observed for GRP78 (14/16 cases, 88%) and HIF1a
(16/16 cases, 100%) in all tumor cells (Figure 3 A–C). At the
invasive front tumor cells displayed a strong nuclear expression of
b-catenin (14/16 cases, 88%) which was found in 70–100% of
tumor cells (Figure 3 D, G). GRP78 expression was markedly
enhanced in 60–100% of tumor cells (14/16 cases, 88%) (Figure 3
E, H). In contrast, HIF1a staining was only found in some cases
with an expression in 10–90% of tumor cells (6/16 cases, 38%;
Figure 3 F) but not in others (10/16 cases 62%; Figure 3 I). Thus,
the coupling of ER-stress with EMT which we found in our
cellular in vitro system was also seen at the invasive front in CRCs
(p = 0.046). Moreover we found a partial coupling of hypoxia and
ER-stress which was not statistically significant (p = 0.433).
ER-stress lasts longer than EMT in CRC cell lines after
reoxygenation
Finally, we wanted to find out if the partial coupling of hypoxia
and ER-stress might be related to revascularization of tumors in
vivo. Therefore in our in vitro system, the CoCl2 containing medium
was replaced by normal culture medium thus mimicking
reoxygenation. After 6 h of CoCl2-treatment tumor cells were
incubated in normal medium for up to 24 h. After hypoxia,
indicated by a considerable increase of HIF1a (Figure 4A, lanes:
Co, H) reoxygenation resulted in the stepwise degradation of
HIF1a in SW480-shZEB1 as well as SW480-control clones
(Figure 4A, lanes: RK, R1, R3, R6, Fig. 4C).
Expectedly, in SW480-shZEB1 cells, no significant change
regarding the amounts of vimentin and GRP78 was found during
hypoxia (Figure 4A and B, lanes: Co, H) and reoxygenation
(Figure 4A and B lanes; RK, R1, R3, R6; SW480-hnZEB1:vi-
mentin: H 1.0-fold; R1/2: 0.9-fold; R1: 1.14-fold; R3: 0.95-fold;
R6: 1.04-fold; all values: p$0.05; GRP78: H: 0.8-fold; R1/2: 0.7-
fold; R1: 0.8-fold; R3: 0.7-fold; R6: 0.96-fold; all values: p$0.05).
In comparison in SW480-control clones, ZEB1 and vimentin
increased initially (Figure 4A lanes RK, R1, Figure 4C) and were
lost late during reoxygenation (Figure 4A lanes; R3, R6, Figure 4C;
SW480-controls: vimentin: H: 1,62-fold; p = 0.029; R1/2: 1,73-
fold, p = 0.006; R1: 2.3-fold, p = 0.02; R3: 2.06-fold, p = 0.002;
R6: 2.07-fold, p = 0.01). Interestingly, the amount of GRP78
increased over reoxygenation-time in SW480-control cells
(Figure 4A and B, lanes: RK, R1, R3, R6; GRP78: H: 1,34-
fold; p = 0.011; R1/2: 1,89-fold, p = 0.02; R1: 2.06-fold, p = 0.017;
R3: 2.12-fold, p = 0.011; R6: 2.1-fold, p = 0.014). Thus, during
reoxygenation cells quickly loose the mesenchymal phenotype
whereas ER-stress persists. Therefore ER-stress is associated with
hypoxia but might also be found under normoxygenation.
Discussion
Correlation between EMT and ER-stress
In the progress of EMT epithelial cells change into dedifferen-
tiated cells which display mesenchymal features. Activation of
EMT promotes tumour cell dissociation and invasion which are
prerequisite for metastasis to distant organs [1,28]. Many CRCs
are characterized by infiltrative growth at the invasive front which
is associated with EMT. During malignant progression and
infiltration, tumour cells are exposed to a variety of environmental
conditions that induce structural alterations of secretory proteins
leading to ER-stress and subsequently UPR [29–31]. In our
experimental setting the mesenchymal phenotype, induced by
changed growth conditions and hypoxia in CRC cell lines, was
characterized by morphological changes, nuclear b-catenin
translocation and significant increased amounts of the EMT
indicator and mesenchymal marker protein vimentin. Additionally
ER-stress response was indicated by elevation of the major player
in ER-stress, the molecular chaperone GRP78, and the 50 kD-
Figure 2. EMT is a prerequisite for ER-stress under conditions of sparse growth, serum starvation and hypoxia. A. SW480-shZEB1
clones show neither EMT indicated by low amounts of vimentin nor ER-stress indicated by low amounts of GRP78 under growth conditions that favor
epithelial (confluent: con.) or mesenchymal (sparsely: spar.) growth conditions compared to SW480-control cells. B. SW480-shZEB1 clones do not
develop EMT or ER-stress under conditions of stress induced by starvation (6 h- serum) compared to SW480-control cells. C. SW480-shZEB1 clones do
not develop EMT or ER-stress under hypoxia-like conditions (6 h; serum free; 100 mM CoCl2) compared to SW480-control cells. Data shown is the
mean 6 SD from three independent experiments; * : p#0.05.
doi:10.1371/journal.pone.0087386.g002
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fragment of the stress sensor ATF6. Thus, our results suggest that
EMT is correlated with ER-stress which is consistent with altered
environmental requirements at the invasive front of CRCs.
Hierarchy of cellular stress, EMT and ER-stress
It is known that stress like hypoxia, changes in the microenvi-
ronment or nutrition might lead to the induction of EMT which is
mediated by the action of the EMT master switch factor ZEB1
[3,4]. In our experimental setting these stress conditions were all
connected with an enhanced level of vimentin and with an ER-
stress response characterized by high GRP78 amounts. In
contrast, cells lacking ZEB1 displayed no EMT and no ER-stress
response. EMT and ER-stress could be reverted by reoxygenation,
which is also dependent on the presence of ZEB1. In vivo, at the
invasive fronts of CRCs where tumour cells display strongly
positive nuclear b-catenin and morphological signs of mesenchy-
mal differentiation GRP78 intensity was also markedly enhanced.
One mode of up-regulating the expression of ZEB1 is via the
action of HIF1a the transcriptional mediator of hypoxia [1,5,32].
Another trigger for inducing ZEB1 is the transcriptional activity of
b-catenin [33,34] as it is found at the invasive front of CRCs
[2,4,35]. According to our findings ER-stress depends essentially
on the presence of ZEB1 and thus on EMT. Therefore cellular
stress like hypoxia or malnutrition might activate HIF1a or b-
catenin which induce ZEB1 and the global EMT program and
finally lead to the induction of ER-stress. Our results based on
hypoxia, serum starvation and growth pattern indicate that there is
a hierarchy in the order: cellular stressREMTRER-stress
(Figure 5).
Elevation of molecular chaperones in CRCs
Molecular chaperones are involved in ER functions by proper
protein folding and assembly as well as controlling the activation of
transmembrane ER stress sensors [36]. Therefore, elevated levels
of chaperones are observed in the context of ER-stress when an
imbalance between the cellular demand for ER-function and ER-
capacity occurs [11]. Increased expression of chaperones has also
been reported in several types of cancer based on proteomic and
immunohistochemical approaches [37–40]. In colon cancer
elevated expression of chaperones was described as well as an
incremental up-regulation in the adenoma-carcinoma sequence
[41–43]. In support with these studies we found GRP78 a member
of the chaperone family and well-known indicator of ER-stress
response which showed a significant up-regulation in SW480 and
HCT116 colon cancer cell lines under conditions of sparse growth.
This situation corresponds with tumor cells at the invasive front in
human CRCs showing EMT and was confirmed in vivo in our
immuohistochemical approach (Figure 3).
Figure 3. Human colorectal carcinomas with EMT show ER stress independent of HIF1a. In central tumor areas of human CRCs b-catenin
was typically localized at the cell membrane (A) whereas only a weak staining was observed for cytoplasmic GRP78 (B) and HIF1a staining was found
to be negative (C). At the invasion front strong nuclear b-catenin was detectable indicating EMT (D, G). In corresponding regions strong cytoplasmic
GRP78 expression was found (E, H). In some of the cases an intense nuclear HIF1a staining was observed (F, with hypoxia), but not in others (I,
without hypoxia) (magnification 2006; scale bar: 100 mm).
doi:10.1371/journal.pone.0087386.g003
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EMT and hypoxia as possible causes for ER-stress
response
Hypoxia is a well-known activator of an ER-stress response. It
occurs in most if not all solid tumors during their carcinogenesis
[9,10]. Moreover, it is a driving force for vascularization and
progression of tumors. Furthermore, it is known, that diverse
molecular and phenotypic changes induced by hypoxia are
consistent with EMT [15,16,26]. In our system the simulation of
hypoxia using CoCl2 caused ER-stress and induced EMT. But it
remains an open question if the ER-stress response in the absence
of hypoxia which was found at the invasive front of CRCs is due to
EMT. Alternatively, it is conceivable that the invasive front is a
zone with highly differing oxygen concentrations. Due to the
different half-life times of HIF1a (,30 min) [44] and GRP78
(,72 h) [13] these zones with GRP78 but missing HIF1a
expression might resemble areas of reoxygenation.
Context specificity of ER-stress and EMT
In several disease patterns and tumor entities a different model
of ER-stress and EMT has been proposed. In primary alveolar
epithelial cells for example it has been suggested that ER stress
induces EMT thereby contributing to lung fibrosis [45]. Similar
models have been put forward for thyroid cell lines, chondrocytes
and pancreatic beta cells [33,34,46,47]. In contrast, in tubular
Figure 4. Development of EMT and ER-stress in SW480-shZEB1
and SW480-control cells under conditions of hypoxia and
reoxygenation. A Confluent growing SW480-shZEB1 and SW480-
control cells were exposed to normoxia and hypoxia-like conditions
(6 h; serum free; 100 mM CoCl2) followed by reoxygenation (normal
medium). Proteins were extracted at conditions of normoxia (control,
Co), hypoxia (H) and reoxygenation (R) after Kh (RK), 1 h (R1), 3 h (R3)
and 6 h (R6). Amounts of HIF1a, ZEB1, vimentin (Vim), GRP78 and b-
actin (b-act as loading control) were determined. B Quantification of the
amount (n-fold) of vimentin (Vim, arrow) and GRP78 in SW480-shZEB1
and SW480-control cells cultured under conditions of normoxia
(control, Co), hypoxia (H) or reoxygenation (R) after Kh to 6 h (RK -
R6). C. The increasing/decreasing amounts of ZEB1- and HIF1a- after 6 h
of exposition to CoCl2 (control, Co and hypoxia, H) followed by different
reoxygenation-times (RK - R6) are exemplarily shown for SW480-
control cells. Data shown is the mean 6 SD from three independent
experiments; * : p#0.05.
doi:10.1371/journal.pone.0087386.g004
Figure 5. Model for the relationship between EMT and ER-
stress. At the invasive front of CRCs cellular stress, like hypoxia or
changes in the microenvironment, induces either the EMT regulator
ZEB1 via HIF1 [1,4] or potentially nuclear translocation of b-catenin [2,4].
ZEB1 induces EMT which represents the driving force for ER-stress and
UPR induction due to GRP78.
doi:10.1371/journal.pone.0087386.g005
EMT Induces ER-Stress Response
PLOS ONE | www.plosone.org 7 January 2014 | Volume 9 | Issue 1 | e87386
epithelial cells albumin induced EMT and ER-stress have been
described which are simultaneously activated through ROS and
cSrc kinase [48]. Therefore the connection of EMT and ER-stress
seems to be highly context specific. In our study we focused on
CRCs with dedifferentiation of tumor cells at the invasive front
and nuclear b-catenin accumulation due to an activation of the
Wnt/b-catenin signaling. In this context our model of EMT
induced ER-stress seems to take place at the invasive front and is
supposed to be mediated by ZEB1. As colorectal carcinogenesis is
very heterogeneous there might be even different connections
between EMT and ER-stress in different types of colorectal tumors
including microsatellite instable tumors (characterized by the
absence of human MUT-L homologue 1 (hMLH1) expression) or
tumors without dysregulated Wnt/b-catenin signalling [49].
ER-stress correlates to stemness and might provide an
alternative therapeutic approach
Interestingly, nuclear b-catenin is not only an inducer and
indicator of EMT [7] but also of cancer stem cells (CSC) [50].
Moreover, induction of EMT results in the induction of tumor
stemness [51]. Thus, the both cellular characteristics EMT and
cancer stemness seem to be interdependent if not the same.
Additionally, both traits, EMT and cancer stemness, are related to
chemoresistance [52] and bad prognosis [53]. Including our results
CSCs should then also be characterized per se by ER-stress.
Therefore, the expression of GRP78 might be a surrogate marker
of stemness [54] as well as chemoresistance [11,55,56]. Thus, our
results are in support with the idea that targeting ER-stress might
be an interesting additive element in a multimodal form of cancer
therapy. This therapy would focus especially on CSCs in CRC
which are known to be chemoresistant to the classical chemother-
apeutic regimens [52]. Targeting the UPR pathways [57] as well
as the expression of the GRP78 gene [58] are currently already in
the focus of this research.
Supporting Information
Figure S1 Two dimensional gel, antibody testing and
confirmation of 50 kD-ATF6 fragment. A. Two dimen-
sional gel of cellular proteins from sparsely growing
human HCT116 cells. Evaluated area (framed): ,47–96 kD/
pI ,4.2–6.1. B. Single experiments. Representative 2-DE
areas from confluent (con.) and sparsely (spar.) grown SW480 and
HCT116 cells are shown. Arrows: vimentin: Vim; GRP78. C.
Testing of antibodies used in this study: Antibodies specific
for b-actin (43 kD – mAb, lane 1); vimentin (55 kD - mAb, lane 2),
GRP78 (75 kD – pAb, lane 3), ZEB1 (170 kD [arrow] –mAB, lane
4), together with b-actin (43 kD); HIF1a (120 kD – mAB, lane 5),
ATF6 (50 kD fragment – mAb, lane 6; accompanied by an intense
25 kD band). The specificity of the used antibodies was
determined by immunoblotting employing protein lysates made
from SW480 or HCT116 cell lines. Specificity was granted when a
single band or patterns of band were seen that represented the
protein under investigation. D. Abundance of the 50 kD-ATF6
fragment in SW480 cells. Protein extracts of epithelially
(confluent: con.) or mesenchymally (sparsely: spar.) growing
SW480 cells as well as SW480 cells under hypoxica-like conditions
(3 h; serum free; 100 mM CoCl2; control: co;) were separated by
SDS-PAGE and immunoblotted.
(TIF)
Figure S2 Hypoxia leads to EMT and ER-stress in CRC
cells. A. Hypoxia-like conditions alter localization of b-catenin
and E-cadherin in confluent growing SW480 and HCT116 cells.
Immunofluorescence-microscopy showed that confluent growing
SW480 as well as HCT116 cells display an epithelial growth
pattern with a membranous localization of b-catenin (a, g; green
fluorescence and E-cadherin (b, h; red fluorescence, c, i: DAPI –
blue fluorescence). After CoCl2 treatment (3 h, 100 mM CoCl2)
SW480 cells changed to a more mesenchymal growing pattern
associated with a cytoplasmic/nuclear localization of b-catenin
and cytoplasmic localization of E-cadherin (d: green fluorescence,
e: red fluorescence f: DAPI – blue fluorescence). HCT116 cells
sustained cell contact, but b-catenin was observed predominantly
in the nucleus, and E-cadherin in the cytoplasm, respectively (k:
green fluorescence, l: red fluorescence, m:: DAPI – blue
fluorescence). B. C. Confluent growing SW480 (B) and HCT116
(C) cells were cultured under conditions of normoxia or hypoxia-
like conditions (serum free; 100 mM CoCl2, 1–9 h). Vimentin
(Vim) was used as a mesenchymal marker and b-actin (b-act) as
loading control. Enhanced amounts of GRP78 were verified after
3 h of CoCl2 addition. HIF1a was detectable after 3 h of CoCl2
incubation, the amount of the 50 kD-ATF6 fragment, was already
enhanced after 1 h of addition of CoCl2. D. Quantification of the
amount (n-fold) of vimentin (Vim) and GRP78 under normoxia
and hypoxia-like conditions. Data shown is the mean 6 SD from
three independent experiments; * : p#0.05.
(TIF)
Table S1 Antibodies used for immunohistochemistry,
dilution, incubation and detection systems.
(DOCX)
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